Christophe Le Terrier

Christophe Le Terrier is a researcher focused on antimicrobial resistance, clinical microbiology, and critical care medicine. His work spans antibiotic development, resistance mechanisms, and emergency department management.

Research Interests: He investigates β-lactamase inhibitors (e.g., taniborbactam, xeruborbactam), drug susceptibility in Gram-negative bacteria (e.g., carbapenem-resistant Enterobacterales), and microbiota dynamics in ICU patients. His studies address urgent clinical challenges like antibiotic stewardship and therapeutic alternatives for multidrug-resistant infections.

Article Trends: Recent publications emphasize in vitro efficacy of novel antibiotic combinations, structural insights into resistance, and emergency care optimization. Over 2023-2025, he has prioritized combating metallo-β-lactamase-mediated resistance and improving outcomes in SARS-CoV-2-related ARDS.